Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263441 · ClinicalTrials.gov registry record · NA
Navigating Insurance Coverage Expansion (NICE)
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 630
- Enrollment target
NCT04263441: Completed NA study, sponsored by University of Chicago.
NCT04263441 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 630 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04263441, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 630 participants
- Enrollment target
Study Summary
The purpose of this research is to measure the effectiveness of an in-person assistance intervention on successful insurance enrollment, types of insurance coverage, rates of linkage to and retention in HIV-related health care, referrals to other HIV-associated health services, and health outcomes. The study population is Black and Hispanic men who have sex with men (MSM) and transgender persons who are at higher risk for HIV. The study team will be testing the hypotheses that in-person health insurance enrollment assistance results in positive outcomes with regard to linkage to and retention in HIV-related health care. Analyses will be used to assess the efficacy of the intervention as an emerging practice.
Primary Outcome
Proportion of participants who completed at least one HIV-related medical visit within 30 days after their baseline HIV test was performed
Interventions
- BEHAVIORAL NICE Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 630 participants |
| Start Date | 2018-10-18 |
| Est. Completion | 2021-05-14 |
| Phase | NA |
What the finished NCT04263441 record still lists
NCT04263441 is an interventional study that assigns participants to a tested intervention. The registered 630 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 0 conditions, and to 1 intervention - of which NICE Intervention is the first listed.
NCT04263441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04263441 about?
NCT04263441 is a clinical study titled "Navigating Insurance Coverage Expansion (NICE)". The purpose of this research is to measure the effectiveness of an in-person assistance intervention on successful insurance enrollment, types of insurance coverage, rates of linkage to and retention in HIV-related health care, referrals to other HIV-associated health services, and health outcomes. ...
What is the current status of trial NCT04263441?
This trial is currently completed. It is a NA study. The enrollment target is 630 participants. The study started on 2018-10-18. Estimated completion is 2021-05-14.
What interventions are being tested in trial NCT04263441?
The interventions under investigation include: NICE Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04263441?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04263441's enrollment target sits among peer trials
630 159th of 2000 higher than 1,841 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- NCT05224440 · 630 participants · NA
National Sponsorship Program for Transitioning Service Members
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI